Skip to main navigationSkip to main content
The University of Southampton
OLIGOMED - Oligonucleotides for medical applications

OLIGOMED Beneficiaries

OLIGOMED comprises 12 beneficiaries: 8 world-class academic units, 1 leading hospital unit, 2 high-quality SMEs, and 1 world-leading pharmaceutical company.

Find below the links to the individual beneficiaries; contact details can be found in the Contact Us page.

Logo AstraZeneca Sweden

AstraZeneca, SE

Dr Shalini Andersson, Cardiovascular, Renal and Metabolic Diseases (CVRM)

Privacy Settings